Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Reperfusion Injury”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Testing effectiveness (Phase 2)Study completedNCT01731457
What this trial is testing

Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function

Who this might be right for
Transplanted Kidney Ischemia Reperfusion Injury
Medical University of Warsaw 94
Not applicableUnknownNCT01605214
What this trial is testing

Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant

Who this might be right for
Primary Graft Dysfunction
University Health Network, Toronto 60
Not applicableLooking for participantsNCT00552357
What this trial is testing

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Who this might be right for
Primary Graft DysfunctionLung Transplantation
University of Pennsylvania 1,150
Not applicableNot Yet RecruitingNCT07595627
What this trial is testing

Hypothermic Machine Perfusion for Liver Graft Preservation

Who this might be right for
Liver TransplantLiver Failure
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)UnknownNCT00506532
What this trial is testing

The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study

Who this might be right for
Lung TransplantationPrimary Graft Dysfunction
Rabin Medical Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT04005469
What this trial is testing

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Who this might be right for
Ischemia Reperfusion InjuryDelayed Graft Function
Rhode Island Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00157716
What this trial is testing

MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)

Who this might be right for
Coronary Artery Bypass Graft SurgeryMyocardial IschemiaReperfusion Injury+1 more
Medicure 900
Testing effectiveness (Phase 2)Study completedNCT01756508
What this trial is testing

Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury

Who this might be right for
End-Stage Renal DiseaseKidney FailureGraft Reperfusion Injury
Russian Academy of Medical Sciences 57
Post-approval studies (Phase 4)Study completedNCT01295567
What this trial is testing

Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?

Who this might be right for
Cardiovascular DiseaseIschemic Heart Disease
Radboud University Medical Center 95
Post-approval studies (Phase 4)WithdrawnNCT01149993
What this trial is testing

Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation

Who this might be right for
Kidney TransplantationRenal TransplantationReperfusion Injury
Georgetown University
Not applicableNot Yet RecruitingNCT07631689
What this trial is testing

Effect of Discarding Initial Reperfusion Blood on Hemodynamics, Liver Function, and 30-Day Outcomes in Liver Transplantation

Who this might be right for
Liver TransplantationIschaemia Reperfusion InjuryPerioperative Complications
University of Sao Paulo General Hospital 132
Testing effectiveness (Phase 2)Study completedNCT04696146
What this trial is testing

Berinert (C1INH) vs Placebo for DGF/IRI

Who this might be right for
End Stage Renal DiseaseChronic Kidney Diseases
Cedars-Sinai Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT01172691
What this trial is testing

Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

Who this might be right for
Liver Transplant
Baylor Research Institute 23
Not applicableUnknownNCT02845154
What this trial is testing

Intermittent Portal and Graft Purge in Living Donor Liver Transplantation

Who this might be right for
HypotensionIschemia Reperfusion Injury
Mansoura University 80
Not applicableStudy completedNCT02059512
What this trial is testing

Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease

Who this might be right for
Ischemic Heart DiseaseBone Marrow CellsCoronary Artery Bypass Grafting (CABG)+1 more
St. Petersburg State Pavlov Medical University 117
Large-scale testing (Phase 3)Ended earlyNCT01564095
What this trial is testing

TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

Who this might be right for
Terminal Liver DiseaseIschemia Reperfusion InjuryGraft Dysfunction+2 more
Ludwig-Maximilians - University of Munich 25
Large-scale testing (Phase 3)UnknownNCT02613195
What this trial is testing

Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation

Who this might be right for
Evidence of Liver Transplantation
RenJi Hospital 20
Not applicableStudy completedNCT01637038
What this trial is testing

The Effect of Remote Ischemic Postconditioning on Liver Graft and Renal Function in Patients Undergoing Living-related Liver Transplantation

Who this might be right for
Ischemia/Reperfusion Injury of Liver GraftIschemia/Reperfusion Injury of KidneyRemote Ischemic Postconditioning
Samsung Medical Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06853223
What this trial is testing

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Who this might be right for
Primary Graft DysfunctionLung TransplantationAcute Lung Injury(ALI)+1 more
University of California, San Francisco 120
Not applicableLooking for participantsNCT05375149
What this trial is testing

Exhaled Breath Particles in Lung Transplantation

Who this might be right for
Lung Transplant RejectionPrimary Graft DysfunctionChronic Rejection of Lung Transplant
Lund University Hospital 150
Load More Results